English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 August 2021, 22:00 HKT/SGT
Share:
    

Source: COVAC
COVAC Token, the First-Ever Crypto COVID Vaccine Token Skyrockets 180x In 2 Months

New York, NY, Aug 23, 2021 - (ACN Newswire) - With vaccine passports touted to remain a permanent fixture of international travel, and even domestic mobility for the foreseeable future, this new crypto initiative seems to be riding the wave of recovery with its $COVAC cryptocurrency. The market appears to be loving it as its price has skyrocketed 180x in 2 months since its launch on PancakeSwap, a decentralised exchange running on the Binance Smart Chain (BSC), on 18 June 2021.

At the time of writing, the $COVAC token price was $0.000162 with a market cap of $2.46mil on PancakeSwap (as of 23 Aug 2021).

See how to buy $COVAC

So, what exactly is COVAC? COVAC, which stands for COVID Vaccine, is a community-driven, fair launched DeFi token used to track the number of COVID vaccinated people around the world. This token was created as a countdown timer to when we can resume travel and get back to our pre-COVID travel lifestyle.

Crypto Launching 2021 | Covac a Covid Vaccination Powered DeFi Token

It currently has a growing base of holders, and is aiming to launch on Hotbit, a centralised exchange on 26 Aug 2021. The ambitious team behind this first-ever crypto COVID Vaccine token is forecasting price to grow a further 50 to 100 folds once the listing hits centralized exchanges.

While still a mystery, the website reveals a team of 7 "doctors" behind COVAC, and our research has shown that they are actually a team with strong backgrounds in the travel tech, ecommerce and gaming industries.

They engage their ~20k Twitter and Telegram community quite frequently covering their product roadmap, and marketing efforts, like airdrop and bounty events. With regards to fear of rug-pulling with most of the new crypto meme projects out there, it's not possible with this project, with their Liquidity Pool (LP) locked up for at least 1 year, and healthy organic growth in their market capitalisation.

The project has done minimal marketing with at best two KOLs on Twitter and two airdrop events so why are people so interested in this token?

COVAC has 2 products, of which the $COVAC token acts as the utility token

  • TokenBlast: A user-friendly multi-transfer tool used to facilitate airdrops, distribute bounties from successful bounty campaigns, token giveaways, and even to distribute coins after an ICO or Security Token Offering.
  • COVACPass+: A digital health pass which enables users to store their vaccination and test results for location check-ins and travel.

Users are required to hold a minimum number of $COVAC tokens in order to use the TokenBlast tool for free, and unlock certain features in COVACPass+. This is quite different from other platforms which typically charge a high upfront or subscription fee to use their products. COVAC is disrupting the market with this model as it effectively makes TokenBlast's cost at least 10 times cheaper than the other equivalent multi-transfer tools.

$COVAC Crypto Products Teaser | Launching 2021

COVACPass+ has not been officially launched yet, but it will eventually use a blockchain oracle to validate the type and authenticity of the vaccine to ensure its validity for the travel route or location check-in points. Once validated with the off-chain database, it executes a smart contract.

How does it work?

19 billion $COVAC tokens were created to commemorate the year COVID-19 was discovered, i.e. 2019, with 3.8 billion in circulation, 5.7 billion will be burned with the token burn schedule following the global vaccination penetration rate. The founding team holds 0.95 billion in $COVAC, and the rest of the 8.55 billion $COVAC will be used for airdrops, marketing, partnership and community-building events.

What's next for COVAC?

Post-listing, the COVAC team aims to launch their COVACPass+ product, and begin strategic partnerships with travel platforms, including hotels, flights, tours, and attractions operators, to promote safe travel and expand the use case of their tokens.

Looks like an exciting journey for this team, poised with strong products and good potential in riding the COVID recovery.

Join the COVAC Community
Website: https://www.covac.io/
Twitter: https://twitter.com/covaccrypto
Telegram: http://t.me/CovacCryptoChat
YouTube: https://www.youtube.com/channel/UCF0n3StJRbrM1oSeaXBQ4GQ



Topic: Press release summary
Source: COVAC


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
H World Group Limited Reports Q1 2024 Financial Results with 17.8% Revenue Growth, Surpassing Expectation  
May 17, 2024 22:29 HKT/SGT
Top executives from SDAIA, Saudi Aramco, Almarai, Saudi Pro League & many others coming to speak at Smart Data & AI Summit  
May 17, 2024 20:09 HKT/SGT
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market  
May 17, 2024 18:00 HKT/SGT
CITIC Telecom CPC's Innovation Excellence Honored with 2 Innovation Awards  
May 17, 2024 16:37 HKT/SGT
London Climate Technology Show 2024 Returns For Third Edition at ExCeL London  
May 17, 2024 15:48 HKT/SGT
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers  
May 17, 2024 15:00 HKT/SGT
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers  
May 17, 2024 15:00 HKT/SGT
Fujitsu chosen for GENIAC project, starts development of large language models for logical reasoning  
Friday, May 17, 2024 1:03:00 PM
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud  
Friday, May 17, 2024 10:19:00 AM
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim  
May 16, 2024 22:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575